LANP mediates neuritic pathology in Spinocerebellar ataxia type 1

被引:19
|
作者
Cvetanovic, Marija [1 ]
Kular, Rupinder K. [1 ]
Opal, Puneet [1 ,2 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Davee Dept Neurol, Chicago, IL 60611 USA
[2] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA
基金
美国国家卫生研究院;
关键词
LANP; pp32; ANP32-A; Spinocerebellar ataxia type 1; SCA1; Neurite outgrowth; CREB-BINDING PROTEIN; SCA1 TRANSGENIC MICE; HUNTINGTONS-DISEASE; REPRESSES TRANSCRIPTION; HISTONE ACETYLATION; GROWTH-FACTOR; CAG REPEAT; TRINUCLEOTIDE REPEAT; GENE-PRODUCT; MOUSE MODEL;
D O I
10.1016/j.nbd.2012.07.024
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Spinocerebellar ataxia type 1 (SCA1) is an autosomal dominant neurodegenerative disease that results from a pathogenic glutamine-repeat expansion in the protein ataxin-1 (ATXN1). Although the functions of ATXN1 are still largely unknown, there is evidence to suggest that ATXN1 plays a role in regulating gene expression, the earliest process known to go awry in SCA1 mouse models. In this study, we show that ATXN1 reduces histone acetylation, a post-translational modification of histones associated with enhanced transcription, and represses histone acetyl transferase-mediated transcription. In addition, we find that depleting the Leucine-rich Acidic Nuclear Protein (LANP)-an ATXN1 binding inhibitor of histone acetylation-reverses aspects of SCA1 neuritic pathology. (c) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:526 / 532
页数:7
相关论文
共 50 条
  • [21] Mesenchymal Stem Cells Ameliorate Cerebellar Pathology in a Mouse Model of Spinocerebellar Ataxia Type 1
    Matsuura, Serina
    Shuvaev, Anton N.
    Iizuka, Akira
    Nakamura, Kazuhiro
    Hirai, Hirokazu
    CEREBELLUM, 2014, 13 (03): : 323 - 330
  • [22] Mesenchymal Stem Cells Ameliorate Cerebellar Pathology in a Mouse Model of Spinocerebellar Ataxia Type 1
    Serina Matsuura
    Anton N. Shuvaev
    Akira Iizuka
    Kazuhiro Nakamura
    Hirokazu Hirai
    The Cerebellum, 2014, 13 : 323 - 330
  • [23] Spinocerebellar ataxia type 20 is genetically distinct from spinocerebellar ataxia type 5
    Lorenzo, D. N.
    Forrest, S. M.
    Ikeda, Y.
    Dick, K. A.
    Ranum, L. P. W.
    Knight, M. A.
    NEUROLOGY, 2006, 67 (11) : 2084 - 2085
  • [24] Purkinje cell loss is the major brain pathology of spinocerebellar ataxia type 10
    Xia, Guangbin
    McFarland, Karen N.
    Wang, Kang
    Sarkar, Partha S.
    Yachnis, Anthony T.
    Ashizawa, Tetsuo
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2013, 84 (12): : 1409 - +
  • [25] Stages of sleep pathology in spinocerebellar ataxia type 2 (SCA2)
    Tuin, I.
    Voss, U.
    Kang, J.-S.
    Kessler, K.
    Rueb, U.
    Nolte, D.
    Lochmueller, H.
    Tinschert, S.
    Claus, D.
    Krakow, K.
    Pflug, B.
    Steinmetz, H.
    Auburger, G.
    NEUROLOGY, 2006, 67 (11) : 1966 - 1972
  • [26] Acupuncture for spinocerebellar ataxia type 1: a case report
    Wang, Yahui
    Wan, Jifeng
    Yang, Tiandi
    Zhang, Zhuoran
    Ren, Dawei
    Zou, Yihuai
    ACUPUNCTURE IN MEDICINE, 2022, 40 (02) : 197 - 198
  • [27] Spinocerebellar ataxia type 2
    Silverman, IE
    ARCHIVES OF NEUROLOGY, 1999, 56 (05) : 628 - 628
  • [28] Maculopathy and Spinocerebellar Ataxia Type 1: A New Association?
    Lebranchu, Pierre
    Le Meur, Guylene
    Magot, Armelle
    David, Albert
    Verny, Christophe
    Weber, Michel
    Milea, Dan
    JOURNAL OF NEURO-OPHTHALMOLOGY, 2013, 33 (03) : 225 - 231
  • [29] Cognitive dysfunctions in spinocerebellar ataxia type 1 and 2
    Pastorello, E.
    Lombardi, S.
    Cappa, F.
    Clementi, M.
    Bisiacchi, P.
    Paganini, D.
    Trevisan, C. P.
    MOVEMENT DISORDERS, 2007, 22 : S14 - S14
  • [30] Pathogenic mechanisms underlying spinocerebellar ataxia type 1
    Leon Tejwani
    Janghoo Lim
    Cellular and Molecular Life Sciences, 2020, 77 : 4015 - 4029